Segment Information (Tables)

6 Months Ended

Mar. 31, 2020

Segment Reporting [Abstract]

Financial Information for Business Segments

The following is the summary of the financial information for the Company’s reportable segments for the three and six months ended March 31, 2020 and 2019 (in thousands):

	Three Months Ended March 31,					Six Months Ended March 31,
		2020		2019		2020		2019
Revenue:
Brooks Semiconductor Solutions Group	$	124,923	$	112,877	$	243,734	$	225,584
Brooks Life Sciences		95,304		85,513		186,993		152,173
Total revenue	$	220,227	$	198,390	$	430,727	$	377,757
Operating income:
Brooks Semiconductor Solutions Group	$	16,707	$	18,903	$	31,707	$	36,166
Brooks Life Sciences		8,117		5,018		14,091		7,678
Reportable segment adjusted operating income		24,824		23,921		45,798		43,844
Amortization of completed technology		2,740		2,791		5,416		4,798
Acquisition accounting impact on inventory contracts acquired		—		—		—		184
Amortization of acquired intangible assets		7,615		6,614		15,525		12,382
Restructuring charges		578		370		1,154		429
Other unallocated corporate (income) expenses		(681)		474		(1,535)		7,047
Total operating income		14,572		13,672		25,238		19,004
Interest income		137		316		836		739
Interest expense		(718)		(8,018)		(1,455)		(13,308)
Loss on extinguishment of debt		—		(9,051)		—		(9,051)
Other expenses, net		(1,399)		(778)		(1,816)		(807)
Income (loss) before income taxes	$	12,592	$	(3,859)	$	22,803	$	(3,423)
			Brooks
			Semiconductor		Brooks
Assets:			Solutions Group		Life Sciences			Total
March 31, 2020			$	275,754	$	949,977	$	1,225,731
September 30, 2019				259,641		909,154		1,168,795

Reconciliation of Reportable Segment Assets to Corresponding Consolidated Amounts

	March 31,		September 30,
	2020		2019
Segment assets	$	1,225,731	$	1,168,795
Cash, cash equivalents, restricted cash, and marketable securities		248,520		342,140
Deferred tax assets		5,080		5,064
Total assets	$	1,479,331	$	1,515,999